US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Apr 24, 2026 (4 months ago)

Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Presence of particulate matter: a white thread-like structure in the cartridge

What was recalled

Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur 441108, INDIA, a) 2 Pens- NDC 70748-346-02; b) 3 Pens - NDC 70748-346-03.

Recalling firm
Lupin Pharmaceuticals Inc.
NDC code
70748-346-02
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0541-2026

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Liraglutide recalls

See all